Letermovir: An enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	157-158
Number of pages	2
Journal	The Journal of Heart and Lung Transplantation
Volume	45
Issue number	1
DOIs	https://doi.org/10.1016/j.healun.2025.09.015
Publication status	Published - Jan 2026

Access to Document

@article{ccff0c5ecfc24743ae09383b4e0242c5,

title = "Letermovir: An enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation",

author = "Skeggs, \{Jack L.\} and Gardiner, \{Bradley J.\}",

year = "2026",

month = jan,

doi = "10.1016/j.healun.2025.09.015",

language = "English",

volume = "45",

pages = "157--158",

journal = "The Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Letermovir

T2 - An enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation

AU - Skeggs, Jack L.

AU - Gardiner, Bradley J.

PY - 2026/1

Y1 - 2026/1

UR - https://www.scopus.com/pages/publications/105024455315

U2 - 10.1016/j.healun.2025.09.015

DO - 10.1016/j.healun.2025.09.015

M3 - Editorial

C2 - 41015400

AN - SCOPUS:105024455315

SN - 1053-2498

VL - 45

SP - 157

EP - 158

JO - The Journal of Heart and Lung Transplantation

JF - The Journal of Heart and Lung Transplantation

IS - 1

ER -